Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

U.S. Global Jets ETF is trending bullishly, approaching the $28.98 resistance level, driven by higher lows and highs since late 2023. Learn more on JETS ETF here.

News Corporation's Q2 2025 results show revenue growth and strategic partnerships. Click to see why NWS is a more attractive investment despite recent stock gains.

A dip in Roblox's daily active users sparked growth concerns on Wall Street and sent the stock plunging as much as 20% on ...

When it comes to this pair, the cosmos is always standing by with a fire extinguisher. “Things are hot between these two—a fiery (Laroi) chart plus a watery (Tate) chart equals a super-steamy ...

While people in each generation are often lumped together, an astrologer explains how to find what sets you apart.

Bob Dylan's Highway 61 Revisited reaches a new peak on multiple charts in the U.K. this week, spurred upward by the movie A ...

Murder Inc. Records founder Irv Gotti has died at 54. He helped launch careers for talent such as Ashanti, DMX and Ja Rule.

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

Egg prices are soaring, and investors are cashing in as shares of Vital Farms and Cal-Maine Foods surge past tech giants, ...

Britain is under pressure from bond dealers and investors to sell fewer long-dated government bonds - which briefly slumped ...

The Dodgers and Cubs will open the 2025 season with the two-game Tokyo Series on March 18-19. We’ll be counting down to that date with our annual preview series, with each story looking ahead to the ...